Paul E. Stephens

机构：UCB Pharma (United Kingdom)

发表论文 62 篇 · 总被引 5981 次 · h-index 34

代表论文

• TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3 (1998 · FEBS Letters · 被引 610)
• Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti-tumor necrosis factor α agents (2007 · Inflammatory Bowel Diseases · 被引 477)
• Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes (1987 · Biochemical Journal · 被引 466)
• The in vitro activity of ADAM‐10 is inhibited by TIMP‐1 and TIMP‐3 (2000 · FEBS Letters · 被引 404)
• The V3 Loops of the HIV-1 and HTV-2 Surface Glycoproteins Contain Proteolytic Cleavage Sites: A Possible Function in Viral Fusion? (1991 · AIDS Research and Human Retroviruses · 被引 243)
• Antibody against the Leu-CAM beta-chain (CD18) promotes both LFA-1- and CR3-dependent adhesion events (1992 · The Journal of Immunology · 被引 214)